T cell receptor alpha joining segment 8 (TRAJ8)

T cell receptor alpha joining segment 8 (TRAJ8) is one of the gene segments in the T cell receptor (TCR) alpha locus. It encodes a joining (J) segment that is utilized by T cells during V(D)J recombination to generate the diversity of the TCR alpha chain. On its own, TRAJ8 does not encode a complete receptor or functional protein product, and it is not a receptor or drug target in isolation[1][2][3]. Instead, it contributes to the generation of the variable region of the TCR alpha chain when joined to variable (V) and constant (C) gene segments[2]. The TCR itself, which consists of complete alpha and beta (or gamma and delta) chains, is essential for recognizing peptide-MHC complexes in immune responses[1][2]. TRAJ8 is not considered a therapeutic target and does not act as a standalone protein. Its only biological role is as a genetic segment assembled into TCR genes[2]. Note: TRAJ8 is not a drug target or functional molecule on its own, but merely a genetic element that participates in the generation of TCR diversity. Use of "TRAJ8" as a target is incorrect if referring to an actual molecular target for drug discovery or therapeutic intervention. The canonical drug target is the *T cell receptor* (TCR), not its individual joining segment[1][2].

Other names

TRAJ8T cell receptor alpha joining 8